Gavi, the Vaccine Alliance was founded to ensure a secure supply of vaccines at affordable prices to developing countries. Since its inception, private sector partnerships, through the mobilisation of resources or the leveraging of expertise and innovation, have been integral to Gavi's success.
Partnering with Gavi creates an opportunity for private sector partners to join a global alliance. Together, we can save lives, create sustainable socio-economic benefits and take a leading role in global development.
Gavi has already protected an entire generation of children and is now working to protect the next by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningitis and yellow fever vaccines. With the support of it sprivate sector partners, through innovative financing and the latest technology – from drones to biometrics – it will continue to save millions more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency.
Supporting Gavi CORE immunisation programmes increases equitable and sustainable use of vaccines, transforming the lives of individuals, helping to boost the economies of lower-income countries and making the world safer for everyone. For more information on Gavi’s priorities see here.
COVAX is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are available worldwide to both high-income and lower-income countries. Gavi leads on procurement and delivery at scale for COVAX: designing and managing the COVAX Facility and the Gavi COVAX Advance Market Commitment to ensure equitable access to a vaccine – wherever they are, and whatever their income level.
Funding Gavi COVAX AMC from the private sector means more doses for lower-income countries and more flexibility to help us prepare for the future – meaning a faster end to the acute phase of this pandemic for the whole world and getting on track for global economic recovery.
By establishing strategic partnerships with leaders in business and industry we are able to use the private sector's financial resources, operational expertise, thought-leadership and innovation to support our goals on vaccine coverage and equity.
We work with private sector partners to develop long-term relationships and create sustainable impact. Corporations can partner with Gavi by sharing industry expertise, technology, and know how to overcome the stubborn bottlenecks that prevent vaccines being available for every child.
Increasing demand for new vaccines is placing ever greater pressure on immunisation delivery systems in developing countries. We are continuously looking to foster innovation, in close collaboration with private businesses and the technology industry, to address these issues.
Launched in 2011, the Matching Fund doubles multiplies private sector partners' impact by doubling their investment. By encouraging business to invest in immunisation, the Gavi Matching Fund has been a critical component in the expansion of our private sector engagement.
How data can reduce waste and get vaccines where they need to be
Real-time temperature data across the vaccine cold chain can help identify problems or risks in the supply chain.
‘The biggest lesson we learned was to just ask’: 5 questions with the Aviation Coalition
Aviation links the world. The sector has been at the heart of the COVID pandemic, from adapting to travel restrictions to transporting vaccines and vital health equipment. Find out how a coalition of companies has been working together to support…
3 health lessons for business from the COVID-19 pandemic
The link between our physical and economic health was made painfully clear during the pandemic, but what lessons can businesses take forward from COVID-19?
How mobile money can transform access to healthcare
Mobile money can help the 1.7 billion people who lack a bank account to access financial services. And it could also have a powerful role to play in healthcare.
How new training approaches are transforming health workers’ ability to deliver vaccines
The pandemic made the challenge of training health workers in lower-income countries even harder. To counter the huge impact COVID-19 is having on health systems worldwide, a collaboration between Gavi and The Rockefeller Foundation is improving…
‘We can’t overstate the power of efficiency’: 5 questions with IFPW
Covering 70% of pharmaceutical goods moved around the world, IFPW is a global group of wholesalers and distributors. Find out how they have been working with Gavi to improve soft skills in the world’s immunization and pharmaceutical supply chains…
How the planes of the future will create a healthier planet
The effects of climate change may lead to future pandemics. As the aviation industry looks to the future, cleaner fuels and electric planes will be key to reducing aviation’s impact on the climate.
How a private-public partnership is training supply chain professionals in the global south
‘Soft skills’, from motivating a team to tapping into networks, provide the vital oil that keeps supply chains moving smoothly. A programme called STEP is bringing together businesses and the public sector to help healthcare managers in the…
Are chatbots better than humans at fighting vaccine hesitancy?
Could artificial intelligence succeed where people have failed in helping people overcome their fears about vaccines?
Why we support COVAX: Mastercard
Mastercard, a long-standing partner of Gavi, recently committed US$ 28 million to the Gavi COVAX AMC, to ensure vaccines are accessible to those that needed them the most, no matter where they live. Vaccines Work spoke to Michael Froman to learn…
COVAX vaccines take to the air by drone
Ghana is not only the first country to receive a shipment of COVAX vaccines, but it will be the first to broaden its reach by delivering them by drone. The new partnership with Zipline and UPS Foundation will see 2.5 million doses delivered this…
Q&A with Keller C. Rinaudo, CEO and Co-Founder of Zipline
Zipline is a California-based automated logistics company that uses autonomous drones to make on-demand, emergency deliveries of high priority products, including emergency and routine vaccines and other health products.
